Furthermore, we noted that the proportions of tumor-reactive CD8 + and CD4 + FoxP3- T-cells were similar, except for MM, which had significantly fewer tumor-reactive CD4 + FoxP3- T-cells than in NSCLC. This evidence concerns the gene CD4 and non-small cell lung carcinoma.